Retina

A new tissue culture model of the retinal pigment epithelium may allow researchers to better understand the impacts of new interventions on the adult human retina

Celebrating its 25th anniversary at the American Academy of Ophthalmology (AAO) Meeting in Las Vegas, Heidelberg Engineering will present its latest diagnostic imaging technologies and services. For a quarter of a century, the company has been committed to delivering solutions to fundamental clinical needs in ophthalmology.

Leading Ophthalmologists from Three Countries Present Real World Clinical Outcomes on Oraya Therapy for Wet AMD

Optogenetics holds the potential of reversing blindness in retinal disease – but how far has the field come, and who are the key players?

A patient has undergone a premium refractive cataract procedure, and they’re unhappy. How are you going to fix it?

Vaccination complications as an explanation for retinal hemorrhage in children should not be accepted clinically or legally, new study data suggests

Vasotide, a small molecule that stops VEGF binding to endothelial receptor molecules, has shown promise in animal models and can be delivered using eyedrops

U.K. Ophthalmologists are the leading adopters of Oraya Therapy for the treatment of wet age-related macular degeneration (AMD), two years after the treatment was introduced in the country.

Anti-VEGF monotherapy may not be adequate for all your wet AMD patients. The Oraya Therapy™ Stereotactic Radiotherapy for Wet AMD, intended as a one-time treatment, has been shown to maintain vision while reducing the number of anti-VEGF injections, providing a viable option for patients with significant fluid in the macula.

Christopher Brand, Consultant Ophthalmic Surgeon, discusses the treatment of recently diagnosed wet AMD patients